Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: T. Gr.: Embracing Diversity -HIV/AIDS/STBBI-Co-infections and Co-morbidities-LOI

McMaster University

$19,936.00

Burden, Risk Factors and Chronic Immune Activation Signature in HIV-related Comorbidities in Black Communities in Ontario

EF 2023-24

Résumé
The Black communities of Canada face disproportionate risks of both HIV and non-communicable diseases (NCDs). Thus, whether the risks, clinical features, pathophysiologic mechanisms, and outcomes of specific HIV-NCD comorbidity outcomes among Black Canadians are significantly different from other populations remains to be determined. This information is critical to developing risk-stratification and precision-medicine-based intervention strategies to reduce the mortality and morbidity associated with NCD-HIV interactions within this population. The aims of this study include epidemiological characterization of HIV-NCD comorbidity among the Black Canadians in Ontario, (2) characterization of the pathophysiology of chronic immune activation linked with HIV-NCD interaction, and capacity-building activities. Initially, we will characterize both the prevalence and incidence of NCD comorbidity or multi-morbidity among Black Canadians living with HIV (PLWH) in participants enrolled in the Ontario HIV Treatment Network Cohort Study (OCS). Secondly, we will assess the role of chronic immune activation as a mediator of health outcomes risk due to HIV-NCD interaction. Here, we will assess whether plasma proteomic, metabolomic, or cellular immune signatures predict specific NCDs and determine whether such biomarker profiles in Black Canadians differ significantly from those of non-Black communities. Finally, we will focus on capacity building and evidence-based knowledge transfer and engagement of Early Career Researchers, preferably from underrepresented communities, who will engage in HIV-NCD research. The interrogation of biomarker signatures as predictors of HIV-NCD comorbidity outcomes is novel and has the potential of underpinning biomarker-based risk stratification tailored to the Black community. This will set the stage for possibly the first instance of -omics informed personalized medicine for Black communities.
Programme
T. Gr.: Embracing Diversity -HIV/AIDS/STBBI-Co-infections and Co-morbidities-LOI
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
500694
Name
Wolday Dawit
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Clinical
Prcname2
Team Grant: Embracing Diversity to Achieve Precision & Health Equity
Projecttitle
Burden, Risk Factors and Chronic Immune Activation Signature in HIV-related Comorbidities in Black Communities in Ontario
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$19,936
Cihrequipment2
$0
Programname2
T. Gr.: Embracing Diversity -HIV/AIDS/STBBI-Co-infections and Co-morbidities-LOI
Keyworddelim
Black Communities; Comorbidity; Hiv; Ontario
Abstract
The Black communities of Canada face disproportionate risks of both HIV and non-communicable diseases (NCDs). Thus, whether the risks, clinical features, pathophysiologic mechanisms, and outcomes of specific HIV-NCD comorbidity outcomes among Black Canadians are significantly different from other populations remains to be determined. This information is critical to developing risk-stratification and precision-medicine-based intervention strategies to reduce the mortality and morbidity associated with NCD-HIV interactions within this population. The aims of this study include epidemiological characterization of HIV-NCD comorbidity among the Black Canadians in Ontario, (2) characterization of the pathophysiology of chronic immune activation linked with HIV-NCD interaction, and capacity-building activities. Initially, we will characterize both the prevalence and incidence of NCD comorbidity or multi-morbidity among Black Canadians living with HIV (PLWH) in participants enrolled in the Ontario HIV Treatment Network Cohort Study (OCS). Secondly, we will assess the role of chronic immune activation as a mediator of health outcomes risk due to HIV-NCD interaction. Here, we will assess whether plasma proteomic, metabolomic, or cellular immune signatures predict specific NCDs and determine whether such biomarker profiles in Black Canadians differ significantly from those of non-Black communities. Finally, we will focus on capacity building and evidence-based knowledge transfer and engagement of Early Career Researchers, preferably from underrepresented communities, who will engage in HIV-NCD research. The interrogation of biomarker signatures as predictors of HIV-NCD comorbidity outcomes is novel and has the potential of underpinning biomarker-based risk stratification tailored to the Black community. This will set the stage for possibly the first instance of -omics informed personalized medicine for Black communities.
Competitiondate
202402
Approvedterm2
0 yr 5 mths
Pinamesdelim
Wolday, Dawit; Boamah, Sheila A; Verschoor, Chris P
Approvedterm
0 an 5 mois
Cihrcontribution2
~ $19,936~ $0~